Loading clinical trials...
Loading clinical trials...
This protocol is a companion imaging study that will add FES-PET/CT imaging to the FORESEE trial at HCI. This study will establish the feasibility of using FES-PET/CT imaging to guide therapeutic deci...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Utah
NCT01984138 · Estrogen Receptor Positive Breast Cancer, Breast Cancer
NCT01992952 · Estrogen Receptor Positive Breast Cancer
NCT01996046 · Estrogen Receptor Positive Breast Cancer, Bone Metastases
NCT00066690 · Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, and more
NCT02668666 · Hormone Receptor Positive Malignant Neoplasm of Breast, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, and more
Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions